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sx2 is believed to play a role in regulating bone development, particularly in sutures of cranial bone. In this study we
nvestigated the effects of retroviral-mediated overexpression of Msx2 mRNA, in both sense and antisense orientations, on
primary cultured chick calvarial osteoblasts. Unregulated overexpression of sense mRNA produced high levels of Msx2
protein throughout the culture period, preventing the expected fall as the cells differentiate. The continued high expression
of Msx2 prevented osteoblastic differentiation and mineralization of the extracellular matrix. In contrast, expression of
antisense Msx2 RNA decreased proliferation and accelerated differentiation. In other studies, we showed that the Msx2
promoter was widely expressed during the proliferative phase of mouse calvarial osteoblast cultures but was preferentially
downregulated in osteoblastic nodules. These results support a model in which Msx2 prevents differentiation and
stimulates proliferation of cells at the extreme ends of the osteogenic fronts of the calvariae, facilitating expansion of the
skull and closure of the suture. © 1999 Academic Press
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iINTRODUCTION
Proper development of the skull requires precise control
of proliferation and differentiation of osteoblast precursors
to balance the need to allow growth to accommodate the
expanding brain with the requirement for timely ossifica-
tion. In these studies we have examined the role of the
homeodomain-containing protein Msx2 in this process.
1 Present address: Department of Genetics and Developmental
Biology, University of Connecticut Health Center, Farmington, CT
06030.
2 Present address: Center for Craniofacial Molecular Biology,
SC School of Dentistry, Los Angeles, CA.
3 To whom correspondence and reprint requests should be ad-
ressed at the Department of Genetics and Developmental Biology,
C1515, University of Connecticut Health Center, 263 Farming-
on Avenue, Farmington, CT 06030. Fax: (860) 679-1047. E-mail:
ichtler@panda.uchc.edu.
298sx2 is part of the Drosophila msh gene family, which
ncludes vertebrate Msx1, 2, and 3. While Msx3 is primarily
expressed in the central nervous system (Shimeld et al.,
1996; Wang et al., 1996), Msx1 and 2 are both expressed in
numerous tissues at many stages of development (David-
son, 1995). Several studies suggest that Msx2 plays a role in
bone development. MSX2 is expressed and regulated by
vitamin D3 in human osteoblasts (Hodgkinson et al., 1993)
and inhibits the cotransfected type I collagen promoter in
ROS 17/2.8 osteosarcoma cells (Dodig et al., 1996; Towler
et al., 1994). Msx2 inhibits the osteocalcin promoter in
transfected MC3T3E1 cells, but stimulates the same pro-
moter in ROS 17/2.8 cells (Towler et al., 1994). Msx2 and
osteocalcin are expressed in a reciprocal pattern during
tooth development (Bidder et al., 1998). Msx2 is strongly
expressed in cells at the extreme ends of the osteogenic
fronts of the calvarial sutures, and a gain-of-function muta-
tion of MSX2 causes Boston-type craniosynostosis (Jabs et
0012-1606/99 $30.00
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299Msx2 Inhibits Osteoblast Differentiational., 1993; Ma et al., 1996), a condition in which cranial
sutures close prematurely. Overexpression of mutant or
wild-type Msx2 driven either by the CMV promoter or by
the mouse Msx2 promoter also causes craniosynostosis (Liu
et al., 1995). In more recent studies, it was shown that
overexpression of Msx2 driven by the mouse Msx2 pro-
moter caused an increased number of proliferative osteo-
genic cells in the sutures of transgenic mice (Liu et al.,
1999). The studies described to date suggest an important
role for Msx2 in skull development; however, because Msx2
is expressed in both osteogenic cells and cells in the dura
mater adjacent to the suture (Kim et al., 1998), it is possible
that Msx2 causes the release of factors from the dura mater
which affect the osteoblastic cells of the suture. Thus we
believe that it is important to determine the direct effect of
Msx2 on osteoblastic cells.
To examine the effect of Msx2 on osteoblasts, we used
the differentiating primary chicken calvarial osteoblast
(cCOB) culture system, which provides a highly manipu-
lable model of osteoblast development. Primary cCOB
cultures show a pattern of bone marker expression and
extracellular matrix maturation which is very similar to
normal bone development (Gerstenfeld et al., 1987). Exog-
enous genes can be stably integrated in essentially all the
cells of a culture by infection with replication-competent
retroviral vectors (Petropoulos and Hughes, 1991). In these
studies, we showed that ectopic overexpression of Msx2
inhibited calvarial osteoblast differentiation in vitro. In
contrast, antisense Msx2 RNA inhibited proliferation and
causes premature differentiation of these cells. We also
examined expression of a transgenic Msx2 promoter-driven
b-galactosidase construct in cultured calvarial osteoblasts,
and we found that the transgene was specifically downregu-
lated in differentiating osteoblasts. These results suggest
that one of the normal biological roles of Msx2 is to inhibit
differentiation and stimulate proliferation in preosteoblas-
tic cells in the osteogenic front of the sutures, thereby
facilitating expansion of the skull bones and closure of the
sutures.
MATERIALS AND METHODS
Primary Chick Calvarial Osteoblast Culture
Chick calvarial osteoblasts were isolated from 15-day-old chick
embryonal calvariae as described in Gerstenfeld et al. (1987) by four
sequential 15-min digestions in 0.05% trypsin (GIBCO, Grand
Island, NY) and 0.1% collagenase P (Boehringer Mannheim) at 37°C
on a rocking platform. Fractions 2–4 were collected and plated at
5000 cells/cm2 in six-well culture plates in DMEM containing 20%
CS. The medium was changed to DMEM containing 10% FCS
4 h later. After the cells became confluent, differentiation me-
ium (BGJb, Fitton–Jackson modification; GIBCO; containing 10%
CS, 50 mg/ml ascorbic acid, and 5 mM b-glycerophosphate) was
sed to maintain the cells for the duration of the experiment. Cells
ere harvested for analysis at different stages of differentiation.
Copyright © 1999 by Academic Press. All rightPrimary Mouse Calvarial Osteoblast Culture and
b-Galactosidase Staining
Primary mouse calvarial cells were isolated as described in
Dodig et al. (1996), using a modification of the method of Wong and
Cohn (1974). Briefly, calvariae from 6- to 8-day-old transgenic mice
containing the Msx2 promoter driving the Escherichia coli LacZ
gene (Liu et al., 1994) were dissected free of sutures and adherent
tissue and then digested with trypsin–collagenase as described for
chick calvaria. Five fractions were collected; the first two were
discarded and fractions 3–5 were pooled, plated at 104 cells/cm2,
and cultured in DMEM with 10% fetal bovine serum. After the
cells reached confluence, the medium was changed to aMEM with
25 mg/ml ascorbate and 5 mM b-glycerophosphate to allow differ-
ntiation. b-Galactosidase staining was carried out using a protocol
iven to us by Dr. Alexandra Joyner. This protocol is essentially as
escribed in Logan et al. (1993), with the exception that 0.1 M
NaPO4, pH 7.3, was used instead of phosphate-buffered saline, and
.1% Na deoxycholate was used in the stain and wash buffers.
Retroviral Vectors and Infection of Chick Primary
Osteoblast Cultures
Full-length chicken Msx2 cDNA was cloned into the ClaI site of
the RCASBP(A) helper-independent retroviral vector (Petropoulos
and Hughes, 1991) in the sense and antisense orientation. As a
control virus we used an RCASBP(A) vector without Msx2 cDNA.
ectors were transfected into producer cells (chicken embryonal
broblasts (CEF)) using the calcium phosphate method. CEF con-
itioned medium with high reverse transcriptase activity, mea-
ured by the procedure described in Petropoulos and Hughes (1991),
nd a titer estimated at 1–3 3 108 infectious particles per milliliter
(Ferrari et al., 1998) was collected and stored at 270°C until use.
cCOBs were infected with 0.5 ml of conditioned medium contain-
ing RCASBP(A)-Msx2, RCAS-Msx2 As, RCAS, or no virus (mock)
on 3 successive days beginning with the first day after the cells
were plated.
Assessment of Mineralization
Mineralization of cultures was determined by von Kossa staining
(Page, 1982).
Immunostaining for Msx2
Cells were fixed in ice-cold 95% ethanol for 1 h, followed by 1 h
in ice-cold 100% methanol and overnight postfixation in 95%
ethanol. Cells were then treated with 100% ethanol:glacial acetic
acid (95:5) for 5 min and then dehydrated with four changes of
ice-cold 100% ethanol. Cells were washed with phosphate-buffered
saline three times for 5 min each and incubated with a polyclonal
rabbit antibody against chicken Msx2 produced and characterized
as previously described (Ferrari et al., 1998). The cells were then
incubated with cy3-conjugated goat anti-rabbit antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA). Fluorescent
black and white 403 images were photographed using Kodak
Tekpan ASA 100 film and a Nikon Optiphot microscope with a
rhodamine filter and digitized using a slide scanner. Color 43
images were photographed using a Diagnostic Instruments Spot
cooled CCD digital camera. For both types of image, all cell types
were photographed using the same exposure conditions. Both types
s of reproduction in any form reserved.
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300 Dodig et al.of image were arranged and labeled and intensity levels adjusted
using Adobe PhotoShop. All adjustments were made on all images
of a group simultaneously, so that no changes in relative intensities
of different images were introduced. Images were printed using a
Kodak dye sublimation printer.
Isolation and Analysis of RNA
RNA was isolated using TRI reagent (Molecular Research Cen-
ter, Inc.) (Chomczinski, 1993). Ten micrograms of total RNA was
separated on a 1% agarose 1.1 M formaldehyde gel and transferred
to nylon membrane (Extra Strength Nytran; Schleicher & Schuell).
Probes for chick Msx2 (Coelho et al., 1991), osteocalcin (Neuge-
auer et al., 1995), osteopontin (Rafidi et al., 1994), bone sialopro-
ein (BSP) (Yang et al., 1995), and alkaline phosphatase (Crawford et
l., 1995) were full-length cDNAs cloned into the EcoRI site of pBS
Stratagene, La Jolla, CA). The probe for chick a1(I) collagen was
isolated from the clone pcg54 (Finer et al., 1987). The cDNA
fragments were gel purified using SpinBind DNA purification
columns (FMC BioProducts, Rockland, ME) and random primer
labeled (Feinberg and Vogelstein, 1983). Hybridization was per-
formed in 50% formamide and 63 SSPE at 42°C (Sambrook et al.,
1989). Hybridization to 18S RNA probe or inspection of ethidium
bromide-stained filters was used to evaluate loading of different
lanes.
Assessment of Cell Proliferation
Cell number of 5-day-old cultures was determined by trypsiniz-
ing the cells from the plate and counting in a hemacytometer using
three independent samplings per plate.
For quantitation of dividing cells, 4-day-old cultures were incu-
bated in 20 mM BrdU (Sigma) overnight at 37°C. BrdU-positive cells
were visualized using a protocol derived from published methods
(Gray, 1985). Cells were fixed with 10% formaldehyde, permeabil-
ized and denatured with 2 M HCl in 0.1% Triton X-100 for 30 min
at 37°C, and washed with 0.1 M sodium borate, pH 8.5. Cells were
incubated with monoclonal anti-BrdU antibody (Sigma) diluted
1:1000 in PBA for 90 min, followed by incubation with TRITC-
conjugated anti-mouse IgG (Sigma). After excitation at 546 nm
FIG. 1. Msx2 mRNA expression during chick calvaria osteoblast
differentiation. Numbers indicate days after plating. Cultures begin
to differentiate after day 7. Hybridization to 18S RNA is shown as
a loading control.
Copyright © 1999 by Academic Press. All rightcells with incorporated BrdU were visualized, photographed, and
counted in 10 random fields using a fluorescence microscope (Zeiss
Axiovert 135) at 103 magnification.
DNA content of 5-day-old cultures was measured by extracting
DNA using the TRI reagent (Molecular Research Center, Inc.)
(Chomczinski, 1993) and measuring the absorbance at 260 nm.
RESULTS
To study the role of Msx2 in osteoblast development, we
used the chick calvarial osteoblast culture system. North-
ern blot analysis reveals that Msx2 expression in differen-
tiating cCOB is highest in early cultures (days 7 and 12),
while in the more differentiated cultures (days 17–27) Msx2
mRNA levels are significantly reduced (Fig. 1). The increase
seen between day 7 and day 12 was not always seen; how-
ever, the decrease seen in later cultures was very reproduc-
ible. This pattern corresponds to that seen in differentiating
murine calvarial osteoblast cultures.
To test whether constitutive overexpression of Msx2
would have an effect on calvarial osteoblast differentiation,
we infected chicken primary osteoblast cultures with a rep-
lication-competent retrovirus expressing Msx2 (RCASBP(A)-
Msx2). Osteoblastic differentiation was determined by
Northern blot analysis using probes for mRNAs which are
characteristically present at high levels in differentiated
osteoblasts. Alkaline phosphatase is the earliest marker to
be induced during osteoblastic differentiation; osteopontin
is generally induced somewhat later, and osteocalcin induc-
tion is the latest marker to be induced (Aubin and Turksen,
FIG. 2. RCASBP(A)-Msx2-mediated expression of Msx2 in chick
alvarial osteoblasts. Northern blot analysis of osteoblast cultures
reated with chick embryo fibroblast conditioned medium (mock),
ontrol RCASBP(A) virus (RCAS), and RCASBP(A)-Msx2 (RCAS-
sx2). The band in lanes labeled MOCK and RCAS is the endog-
nous Msx2 transcript. The arrowhead indicates the only retrovirus
transcript which can be translated to produce Msx2 protein.1996). We also probed for type I collagen, which, although it
s of reproduction in any form reserved.
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levels during differentiation. Although some reports indi-
cate that type I collagen expression is highest in the early
proliferative phase of osteoblast culture (Owen et al., 1990),
our studies have found that this marker is highest in
post-proliferative differentiating cultures (Dodig et al., 1996
and unpublished results). Control experiments demon-
strated that exposure of cCOB cultures to chick embryo
fibroblast conditioned medium (mock infection) or to
RCASBP(A) virus had no effect on differentiation (data not
shown). Msx2 overexpression in infected cCOB cultures
was examined by Northern blot analysis of Msx2 mRNA
(Fig. 2). The arrowhead indicates the spliced retroviral RNA
which is the only RNA species which can be translated to
produce Msx2 protein. The larger RNAs have upstream
reading frames which encode the viral gag, pol, and env
proteins and thus cannot translate the Msx2 cistron (Petro-
poulos and Hughes, 1991). In addition, immunostaining
FIG. 3. Immunohistochemistry detecting Msx2 protein in
RCASBP(A)-Msx2-infected (A, D), control (B, E), and RCASBP(A)-
Msx2 antisense-infected (C, F) chick calvarial osteoblasts. A–C are
images taken with a 403 objective of cells replated at low density
to allow visualization of individual cells. D–E are images taken
with a 43 objective of primary cells at high density to allow
visualization of overall intensity of staining. Phase-contrast visu-
alization of these cultures indicated that the three types of cells
were at similar densities.using polyclonal Msx2 antibodies indicated that most if not
Copyright © 1999 by Academic Press. All rightall of the cells in the RCASBP(A)-Msx2 infected cultures
(Figs. 3A and 3D) had strongly staining nuclei, in contrast to
the control cultures (Figs. 3B and 3E), which were more
lightly stained, reflecting the moderate expression of endog-
enous Msx2. The proliferation and appearance of undiffer-
entiated 5-day-old cultures was not affected by Msx2 (Table
1 and data not shown). To determine the effect of Msx2 on
differentiation into mature osteoblasts, we examined the
expression of osteoblastic markers in the cultures by North-
ern blot analysis. Expression of type I collagen and os-
teopontin was decreased (Fig. 4A), and alkaline phosphatase
and osteocalcin in the 28-day-old cultures were barely
detectable (Fig. 4B), compared with control cultures in-
fected with RCASBP(A) or mock-infected controls. The
m o s t d r a m a t i c m o r p h o l o g i c a l e f f e c t o f
RCASBP(A)-Msx2 infection was the absence of mineraliza-
tion of the extracellular matrix, while mineralization was
demonstrated by both mock and RCASBP(A) control cul-
tures (Fig. 4C). These experiments were repeated three
times with very reproducible results in each case.
In a second series of experiments we engineered a retro-
virus expressing Msx2 RNA in the antisense orientation
(RCASBP(A)-Msx2As). Immunostaining with Msx2 anti-
bodies demonstrated decreased levels of Msx2 protein in
antisense-treated cultures compared to controls (compare
Figs. 3C and 3F to Figs. 3B and 3E) Differentiation of
antisense-infected cultures was accelerated as shown by
earlier expression of bone markers. Type I collagen mRNA
in Msx2 antisense-infected cultures was increased com-
pared to RCASBP(A)-infected cultures on day 7, indicating
that the Msx2 antisense has accelerated the normal differ-
entiation of these cultures. By day 12 collagen mRNA levels
were similar in controls and antisense-treated cultures (Fig.
5A). This is consistent with our observation that endoge-
nous levels of Msx2 are decreasing during this time period,
TABLE 1
Effect of Msx2 Sense and Antisense on Cell Proliferation
RCAS Msx2As Msx2
Cell number
Expt 1 38.7 6 0.7 (3) 29.3 6 1.4 (3)* 38.0 6 0.6 (3)
Expt 2 19.3 6 2.0 (3) 15.3 6 1.2 (3)* 20.3 6 0.3 (3)
Expt 3 35.0 6 1.7 (3) 26.3 6 0.3 (3)* 35.0 6 1.5 (3)
DNA content
Expt 1 11.8 mg 8.5 mg 11.5 mg
Expt 2 16.3 mg 9.5 mg 13.8 mg
BrdU incorporation 94.1 6 7.4 (10) 72.0 6 2.7 (10)* 94.1 6 7.4 (10)
Note. Cell number and BrdU incorporation are shown as the
mean 6 standard error of the mean, with the number of replicates
in parentheses. DNA content was determined by quantitation of
DNA in 5 or 6 35-mm dishes, then calculation of the amount of
DNA per dish. All assays were done on 5-day-old cultures.* Values significantly different from RCAS values at P , 0.05.
s of reproduction in any form reserved.
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302 Dodig et al.allowing increased expression of type I collagen, which is a
relatively early marker of differentiation. Osteopontin
mRNA was slightly induced on day 7 and was strongly
induced on day 12, when very little endogenous mRNA was
present in the control cultures. Alkaline phosphatase was
induced relative to control on days 7 and 12. Osteocalcin
was strongly induced on day 12 of culture, when the control
cultures showed very minor induction of this mRNA.
Mineralization of the extracellular matrix was also strongly
induced compared to control in day 12 cultures (Fig. 5C).
These observations, which were consistently seen in three
separate experiments, support the conclusion of the Msx2
overexpression studies, suggesting that endogenous Msx2
inhibits osteoblastic differentiation during the early prolif-
erative phase of in vitro osteoblast differentiation.
Msx2 antisense-infected cultures appeared to be less
proliferative than control cultures. Since proliferation is
FIG. 4. Effect of Msx2 on osteoblast markers in 28-day osteoblast
Effect of Msx2 on alkaline phosphatase (AP) and osteocalcin (OC).
Black spots are areas of mineralization. Labels are as in Fig. 3 captoften inversely correlated with differentiation, we exam-
Copyright © 1999 by Academic Press. All rightned three indices of proliferation in three separate experi-
ents comparing Msx2 antisense and control cultures.
ultures infected with RCASBP(A)-Msx2As demonstrated
5–30% fewer cells, less DNA per plate, and a reduced
umber of BrdU-positive cells compared with cultures
nfected with control virus (Table 1), indicating that endog-
nous Msx2 stimulates proliferation in calvarial osteoblas-
ic cells.
Although previous studies showed that Msx2 mRNA
xpression decreases during mouse calvarial osteoblast dif-
erentiation (Dodig et al., 1996), Msx2 mRNA levels were
still substantial at a time when the cultures were undergo-
ing differentiation. It could not be determined using these
Northern blot studies whether Msx2 decreased in all cells
in the culture at the same rate or if Msx2 decreases more
rapidly in osteoblastic nodules than in surrounding nonos-
teoblastic cells. To address this question, we used trans-
res. (A) Effect of Msx2 on Col1a1 and osteopontin (OP) mRNA. (B)
ffect of Msx2 on mineralization as revealed by von Kossa staining.
Msx2 a and b are duplicate experiments.cultu
(C) E
ion.genic mice containing 5.3 kb of the Msx2 gene 59 flanking
s of reproduction in any form reserved.
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303Msx2 Inhibits Osteoblast Differentiationsequence driving b-galactosidase. Previous studies (Liu et
al., 1994; 1999; and our unpublished observations) have
shown that this transgene is expressed in the calvarial
sutures in a pattern similar to that of the endogenous gene.
Calvarial osteoblasts from these mice were cultured under
conditions which allow in vitro differentiation and stained
for b-galactosidase at various stages. Although sutures were
removed from the calvariae, so that most of the plated cells
would not have expressed Msx2 in vivo, by day 1 after
plating most of the cells were beginning to express the
transgene (Fig. 6A), and by day 4 almost all cells expressed
FIG. 5. Effect of Msx2 antisense (Msx2As) on osteoblast differen
ol1a1 and osteopontin (OP) mRNA levels. (B) Effect of Msx2 on a
he blot shown in A, so the 18S normalization applies here as well.
lack spots are areas of mineralization.b-galactosidase (Fig. 6B). By day 11, when osteoblastic
Copyright © 1999 by Academic Press. All rightodules had begun to form, b-galactosidase was restricted
to cells between the nodules (Fig. 6C). By day 16
b-galactosidase was restricted to the cells immediately
surrounding the nodules (Fig. 6D). This pattern of expres-
sion is consistent with the hypothesis that Msx2 inhibits
osteoblastic differentiation.
DISCUSSION
In these studies we examined the role of Msx2 in skull
n after 7 (d7) or 12 (d12) days in culture. (A) Effect of Msx2As on
e phosphatase (AP) and osteocalcin (OC). B is a rehybridization of
ffect of Msx2 on mineralization as revealed by von Kossa staining.tiatio
lkalin
(C) Ebone development. In order to directly assess the function
s of reproduction in any form reserved.
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304 Dodig et al.of Msx2 in this process, we forced continued expression of
Msx2 in calvarial osteoblasts beyond the stage at which the
ndogenous gene is normally downregulated. We found that
steoblastic differentiation was strongly inhibited. Anti-
ense inhibition of Msx2 expression stimulated differentia-
tion and decreased proliferation, further supporting the role
of endogenous Msx2 in inhibiting differentiation and sug-
gesting that Msx2 also stimulates proliferation. Overexpres-
sion of Msx2 did not appear to stimulate proliferation. This
may be because the endogenous levels of Msx2 present in
the cultures coupled with serum growth factors may have
stimulated maximal proliferation, such that higher levels of
Msx2 were not able to stimulate increased proliferation.
Previous studies had indicated that Msx2 expression
decreases as calvarial osteoblast cultures differentiate. To
investigate this observation in greater detail, we used
transgenic mice containing an Msx2 promoter-driven
b-galactosidase transgene. We found that this transgene
s expressed in calvarial cells cultured in vitro, despite
he fact that the sutures and outer cells of the perios-
eum, which contain the vast majority of Msx2-
xpressing cells in the calvaria (Jabs et al., 1993), were
emoved before isolation of the cells which were plated
or the experiments. This observation is consistent with
revious studies showing that endogenous Msx2 mRNA
s expressed in cultured mouse calvarial cells but not in
alvariae with the sutures and part of the periosteum
emoved (Dodig et al., 1996). The induction of Msx2 in
ells which did not express Msx2 in vivo suggests the
ossibility that all calvarial osteoblasts may be capable of
FIG. 6. Msx2 promoter-driven b-galactosidase transgene expres-
ion during calvarial osteoblast development. Calvarial osteoblasts
rom 6- to 8-day-old transgenic mice containing 25.2/lacZ were
ultured for 1, 4, 11, and 16 days (A, B, C, and D, respectively) and
hen stained for b-galactosidase activity. Arrows in C and D point
o osteoblastic nodules.xpressing Msx2 in vivo and that a specific signal induces
Copyright © 1999 by Academic Press. All rightsx2 in the cells in the suture area. Alternatively Msx2
xpression may be constitutive in calvarial osteoblast
recursors, but may be suppressed in cells outside the
uture. The second possibility is consistent with the fact
hat Msx2 is expressed in migrating cranial neural crest
ells, which include the precursors of calvarial osteo-
lasts. It appears that the conditions allowing expression
f Msx2 are mimicked by in vitro culture. Analysis of
b-galactosidase expression during in vitro differentiation
of these cultures indicated that the Msx2 transgene was
downregulated first in the osteoblastic nodules and only
later in the internodular cells. This observation further
supports the hypothesis that Msx2 inhibits osteoblastic
ifferentiation.
Our results, combined with previous studies on Msx2,
an be used to construct a model for the role of Msx2 in
alvarial bone development and to explain why increased
sx2 function causes craniosynostosis (Fig. 7). Msx2 is
xpressed primarily in cells at the extreme end of the
steogenic front of the suture and in cells in between the
utures. There is decreased or absent expression in the
ells flanking the front. We believe that Msx2 expression
onstrains the committed preosteoblastic cells in the
steogenic front in an undifferentiated stage and probably
timulates proliferation to some degree, maintaining a
one of rapid lateral bone growth at the edge of the
alvariae (Fig. 7A). Downregulation of Msx2 expression is
ecessary for the progression of these cells further into
he osteoblastic lineage. The Msx2 gain-of-function mu-
tation found in Boston-type craniosynostosis (Jabs et al.,
993), or increased expression of normal Msx2 in trans-
enic mice (Liu et al., 1995), may lead to an expansion of
he zone of undifferentiated, proliferating cells which
ake up part of the osteogenic front (Fig.7B). The in-
rease in the size and growth rate of this group of cells
isrupts the synchronization between calvarial bone
rowth and expansion of the brain, which is needed to
aintain the proper distance between the skull bones,
herefore the osteogenic ridges from neighboring calvar-
al bones meet prematurely (Fig. 7C). In studies on the
alvariae of Msx2-overexpressing transgenic mice, it was
ound that the osteogenic fronts of mice expressing Msx2
rom the Msx2 promoter show enhanced growth and in-
reased BrdU labeling compared to those of control mice,
onsistent with our hypothesis (Liu et al., 1999). We
ypothesize that in the human the juncture of two os-
eogenic fronts triggers downregulation of Msx2, allow-
ing osteoblastic differentiation and final closure of the
suture. In the mouse, fusion of the sutures does not occur
in 4-month-old adult mice (Zimmerman et al., 1998),
therefore Msx2 may not be downregulated. Mice express-
ing Msx2 driven by the CMV promoter had normal ossi-
fied bone (Liu et al., 1995). Based on the results of the
current studies, we would predict that this would not
s of reproduction in any form reserved.
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305Msx2 Inhibits Osteoblast Differentiationoccur if the Msx2 gene was expressed in mature osteo-
blasts.
The role that we have proposed for Msx2 in modulating
cell division and differentiation of specific preosteoblastic
cells is consistent with the effects of the “selector” homeo-
proteins on Drosophila development, which include modu-
lation of rates of cell division and differentiation into
specific cell types (Biggin and McGinnis, 1997).
Winograd et al. (1997) have analyzed transgenic mice
containing the human MSX2 gene and have found an
xtremely severe phenotype characterized by perinatal le-
FIG. 7. Model of the role of Msx2 in normal skull development ahality and multiple craniofacial malformations, often char- (
Copyright © 1999 by Academic Press. All rightcterized by loss of skeletal structures. This apparent dis-
repancy with the results of Liu et al. (1995) may be because
ultiple integrated copies of the entire human MSX2 gene
ocus produced much higher levels of MSX2 protein than
he transgene used in the studies of Liu et al., or MSX2 may
ave been expressed ectopically. The pattern and levels of
xpression of the MSX2 protein were not assessed by
inograd et al., 1997.
Our model predicts that inactivation of the Msx2 gene
ould cause delayed closure of the cranial sutures. Al-
hough an Msx2 gene knockout mouse has been described
he role of its overexpression in craniosynostosis.Maas and Bei, 1997), the time of closure of the cranial
s of reproduction in any form reserved.
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306 Dodig et al.sutures was not reported. It will be of interest to examine
suture closure in further studies of this mouse.
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